$CRTO

Criteo stock price target maintained at $21 by StoneX on AI progress

StoneX maintained a Buy rating and $21.00 price target for Criteo (CRTO) after a meeting with the company, citing AI progress and undervaluation. CRTO trades at $16.50, with 27% upside potential. Revenue declined 4.2% over the last year, but earnings beat estimates in Q2 2026. Bernstein SocGen downgraded CRTO to Market Perform, citing profit warning concerns.

Original reporting
Published Sep 21, 2026, 2:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 3:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CRTO
Bullish
medium confidence
Mentioned
$CRTO · $SNEX
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CRTOBullishMed
01

Why it matters

Analyst price target raise could attract buyers and support short-term upside.

02

Market read

New price target may influence trading decisions for CRTO and peers in ad-tech.

03

What to watch

OpenAI integration still experimental and revenue decline persists.

Relevance 6/10Novelty 5/10Timing: today

Background

StoneX met with Criteo's IR and reaffirmed its buy stance, citing AI integration and valuation metrics.

Company-level read

Ticker impact

$CRTOBullishMedium confidence
Context

StoneX reiterated a Buy rating and raised the price target to $21, a new analyst action for Criteo.

Expected impact

Potential modest price increase toward $21 target.

Evidence & confidence

Target implies ~27% upside from $16.50, but execution risk remains.

Market effects

May lift sentiment in the performance media advertising sector.

Limited to US-listed ad-tech stocks.

Minor impact globally.

Counterpoint

Target may be overly optimistic given declining revenue trends.

Key entities

  • Criteo S.A.

    French ad-tech firm listed on NASDAQ.

  • StoneX

    Research firm providing the rating and target.

Related articles

$COHRMed

Coherent Soars 6%, Lumentum Up 8% as StoneX Starts Both With Buy, Sees 103% Upside

Coherent (COHR) and Lumentum (LITE) shares rose 6% and 8% respectively after StoneX initiated coverage with Buy ratings and price targets of $425 and $1,200. StoneX cites Coherent's six-inch InP laser production and Lumentum's market position in high-speed InP lasers and cloud transceivers. Coherent's earnings estimates have been rising, with fiscal 2027 EPS expected at $9.39. StoneX's target implies a 45x multiple on fiscal 2027 earnings, above Coherent's five-year average of 24x.

$RMBSMed

Rambus stock price target maintained at $165 by StoneX on product momentum

StoneX maintained a Buy rating and $165 price target on Rambus (NASDAQ:RMBS) after its Q3 2026 results and Q4 guidance beat expectations. The company reported $0.84 EPS and $218.3M revenue, driven by strong product and silicon IP demand. Other analysts raised targets but kept Neutral ratings. Rambus shares are down 50% from their 52-week high, trading at 29x StoneX's earnings estimates.

High

Lumentum Stock Jumps 8% on StoneX $1,200 Target

Lumentum's stock rose 8.19% to $818.10 after StoneX initiated coverage with a Buy rating and a $1,200 price target. The company's products are used in AI and data-center infrastructure. Coherent and Applied Optoelectronics also gained. Lumentum's next earnings report is due on 5 November.

$LITEHigh

Lumentum, Coherent Rise as StoneX Backs Optical Names

Lumentum LITE and Coherent COHR shares rose 7.99% and 5.16% respectively after StoneX initiated coverage with Buy ratings. StoneX set a $1,200 price target for Lumentum, above its 52-week high. MaxLinear MXL CEO highlighted strong demand for optical components, with estimates for pluggable units rising to 200 million by 2027-2028.

$LITEHigh

Lumentum and Coherent Stocks Jump 3% as StoneX Unveils Bold Price Targets

Lumentum (LITE) and Coherent (COHR) shares rose 3% after StoneX initiated coverage with Buy ratings and price targets of $1,200 and $425, respectively. Analyst Cody Acree cited growing demand for optical tech in AI data centers and near-packaged optics deployment acceleration. Coherent plans to expand indium phosphide production and expects $3B quarterly revenue by late 2027.